110 related articles for article (PubMed ID: 16988660)
21. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.
Hacein-Bey-Abina S; von Kalle C; Schmidt M; Le Deist F; Wulffraat N; McIntyre E; Radford I; Villeval JL; Fraser CC; Cavazzana-Calvo M; Fischer A
N Engl J Med; 2003 Jan; 348(3):255-6. PubMed ID: 12529469
[No Abstract] [Full Text] [Related]
22. Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.
Tuovinen EA; Grönholm J; Öhman T; Pöysti S; Toivonen R; Kreutzman A; Heiskanen K; Trotta L; Toiviainen-Salo S; Routes JM; Verbsky J; Mustjoki S; Saarela J; Kere J; Varjosalo M; Hänninen A; Seppänen MRJ
J Clin Immunol; 2020 Apr; 40(3):503-514. PubMed ID: 32072341
[TBL] [Abstract][Full Text] [Related]
23. LMO2 and gene therapy for severe combined immunodeficiency.
Fischer A; Abina SH; Thrasher A; von Kalle C; Cavazzana-Calvo M
N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15190153
[No Abstract] [Full Text] [Related]
24. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS
Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490
[TBL] [Abstract][Full Text] [Related]
25. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency.
Puck JM; Pepper AE; Henthorn PS; Candotti F; Isakov J; Whitwam T; Conley ME; Fischer RE; Rosenblatt HM; Small TN; Buckley RH
Blood; 1997 Mar; 89(6):1968-77. PubMed ID: 9058718
[TBL] [Abstract][Full Text] [Related]
28. Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.
Westwood JA; Murray WK; Trivett M; Shin A; Neeson P; MacGregor DP; Haynes NM; Trapani JA; Mayura-Guru P; Fox S; Peinert S; Honemann D; Prince HM; Ritchie D; Scott AM; Smyth FE; Smyth MJ; Darcy PK; Kershaw MH
Gene Ther; 2008 Jul; 15(14):1056-66. PubMed ID: 18369322
[TBL] [Abstract][Full Text] [Related]
29. The significance of LMO2 expression in the progression of prostate cancer.
Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
[TBL] [Abstract][Full Text] [Related]
30. Good news for gene therapy.
Berns A
N Engl J Med; 2004 Apr; 350(16):1679-80. PubMed ID: 15084702
[No Abstract] [Full Text] [Related]
31. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
Hacein-Bey-Abina S; Garrigue A; Wang GP; Soulier J; Lim A; Morillon E; Clappier E; Caccavelli L; Delabesse E; Beldjord K; Asnafi V; MacIntyre E; Dal Cortivo L; Radford I; Brousse N; Sigaux F; Moshous D; Hauer J; Borkhardt A; Belohradsky BH; Wintergerst U; Velez MC; Leiva L; Sorensen R; Wulffraat N; Blanche S; Bushman FD; Fischer A; Cavazzana-Calvo M
J Clin Invest; 2008 Sep; 118(9):3132-42. PubMed ID: 18688285
[TBL] [Abstract][Full Text] [Related]
32. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
[TBL] [Abstract][Full Text] [Related]
33. DNA transposons for modification of human primary T lymphocytes.
Huang X; Wilber A; McIvor RS; Zhou X
Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
[TBL] [Abstract][Full Text] [Related]
34. Development of functional human immune system with the transplantations of human fetal liver/thymus tissues and expanded hematopoietic stem cells in RAG2-/-gamma(c)-/- MICE.
Joo SY; Choi BK; Kang MJ; Jung DY; Park KS; Park JB; Choi GS; Joh J; Kwon CH; Jung GO; Lee SK; Kim SJ
Transplant Proc; 2009 Jun; 41(5):1885-90. PubMed ID: 19545750
[TBL] [Abstract][Full Text] [Related]
35. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
36. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.
Pike-Overzet K; van der Burg M; Wagemaker G; van Dongen JJ; Staal FJ
Mol Ther; 2007 Nov; 15(11):1910-6. PubMed ID: 17726455
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral vector gene transfer into human T cells.
Verhoeyen E; Costa C; Cosset FL
Methods Mol Biol; 2009; 506():97-114. PubMed ID: 19110622
[TBL] [Abstract][Full Text] [Related]
38. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review).
Van Dyck F; Declercq J; Braem CV; Van de Ven WJ
Int J Oncol; 2007 Apr; 30(4):765-74. PubMed ID: 17332914
[TBL] [Abstract][Full Text] [Related]
39. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
40. Burn injury induces the expression of cystine/glutamate transporter (x(c)(-)) in mouse T cells.
D'Elia M; Patenaude J; Dupras C; Bernier J
Immunol Lett; 2009 Aug; 125(2):137-44. PubMed ID: 19576933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
